ACHC Документы SEC - Acadia Healthcare Company, Inc.- Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

LEI	5493005CW985Y9D0NC11
CIK	1520697

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Acadia Healthcare Company, Inc.

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

August 5, 2025	EX-99	ACADIA HEALTHCARE REPORTS SECOND QUARTER 2025 RESULTS Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Exhibit 99 ACADIA HEALTHCARE REPORTS SECOND QUARTER 2025 RESULTS Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition FRANKLIN, Tenn.
August 5, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadia Hea
August 5, 2025	EX-10.2	Form of Cash Retention Award Agreement. Exhibit 10.2 Personal and Confidential [Date] [Name] [Email Address] Re: Retention Bonus Agreement Dear : Acadia Management Company, LLC, a Delaware limited liability company (the “Company”), is pleased to offer you the opportunity to earn a cash retention bonus (the “Bonus’’) on the terms and subject to the conditions set forth in this letter agreement (this “Agreement”). 1. Bonus Payment. The to
August 5, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 5, 2025 (August 4, 2025) Aca UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 5, 2025 (August 4, 2025) Acadia Healthcare Company, Inc.
May 30, 2025	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables FORM S-8 (Form Type) ACADIA HEALTHCARE COMPANY, INC.
May 30, 2025	S-8	As filed with the Securities and Exchange Commission on May 30, 2025 As filed with the Securities and Exchange Commission on May 30, 2025 Registration No.
May 30, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 29, 2025 Acadia Healthcare Company, Inc.
May 12, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadia He
May 12, 2025	EX-99	ACADIA HEALTHCARE REPORTS FIRST QUARTER 2025 RESULTS AFFIRMS FULL YEAR 2025 GUIDANCE Exhibit 99 ACADIA HEALTHCARE REPORTS FIRST QUARTER 2025 RESULTS AFFIRMS FULL YEAR 2025 GUIDANCE FRANKLIN, Tenn.
May 12, 2025	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities. Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of March 31, 2025, guarantors of the Company’s 5.
May 12, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 12, 2025 (May 12, 2025) Acadia Healthcare Company, Inc.
April 10, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 10, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 10, 2025	EX-4.1	Indenture, dated March 10, 2025, by and among Acadia Healthcare Company, Inc., the guarantors party thereto and U.S. Bank Trust Company, National Association, as Trustee. Exhibit 4.1 ACADIA HEALTHCARE COMPANY, INC. AND EACH OF THE GUARANTORS PARTY HERETO $550,000,000 7.375% SENIOR NOTES DUE 2033 INDENTURE Dated as of March 10, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 46 Section 1.03. Inapplicability of Trust I
March 10, 2025	EX-99.1	ACADIA HEALTHCARE ANNOUNCES LAUNCH OF $500 MILLION SENIOR NOTES OFFERING Exhibit 99.1 ACADIA HEALTHCARE ANNOUNCES LAUNCH OF $500 MILLION SENIOR NOTES OFFERING FRANKLIN, Tenn. (March 5, 2025) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of $500 million in aggregate principal amount of senior notes due 2033 (the “Notes”), subject to market conditions and other conside
March 10, 2025	EX-99.2	ACADIA HEALTHCARE ANNOUNCES PRICING OF $550 MILLION SENIOR NOTES DUE 2033 Exhibit 99.2 ACADIA HEALTHCARE ANNOUNCES PRICING OF $550 MILLION SENIOR NOTES DUE 2033 FRANKLIN, Tenn. (March 6, 2025) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its private offering (the “Offering”) of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the “Notes”), which represents an increase of $50 millio
March 10, 2025	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2025 (March 5, 2025) Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of inc
February 28, 2025	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2025 Acadia Healthcare Company, Inc.
February 28, 2025	EX-10.1	Credit Agreement, dated as of February 28, 2025, among Acadia Healthcare Company, Inc., the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and JPMorgan Chase Bank, N.A., as Administrative Agent. Exhibit 10.1 CREDIT AGREEMENT Dated as of February 28, 2025, among ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation, as the Borrower, JPMORGAN CHASE BANK, N.A., as Administrative Agent and as the Swing Line Lender and an L/C Issuer, WELLS FARGO SECURITIES, LLC, as Syndication Agent, MUFG BANK, LTD. and THE HUNTINGTON NATIONAL BANK, as Co-Documentation Agents and THE OTHER LENDERS AND L/C IS
February 27, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2025 (February 27, 2025) Acadia Healthcare Company, Inc.
February 27, 2025	EX-21	Subsidiaries of the Company. Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Delaware Acadia Assurance Company Acadia Battle Creek Holdings, LLC Acadia Capital Investments, LLC Acadia Central Florida JV Holdings, LLC Tennessee Tennessee Delaware Delawa
February 27, 2025	EX-19	Acadia Healthcare Company. Inc. Insider Trading Policy. Exhibit 19 Acadia Healthcare Company, Inc. Insider Trading Policy and Disclosure Policy Amended and Restated as of February 13, 2025 PURPOSE This Insider Trading and Disclosure Policy (the “Policy”) applies to all transactions in the securities of Acadia Healthcare Company, Inc. (the “Company”) and the handling of confidential information about the Company and the companies with which the Company
February 27, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 ACADIA HEALTHC
February 27, 2025	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of December 31, 2024, guarantors of the Company’s 5.
February 27, 2025	EX-99	ACADIA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS COMPANY PROVIDES FULL YEAR AND FIRST QUARTER 2025 GUIDANCE, ANNOUNCES $300 MILLION SHARE REPURCHASE AUTHORIZATION Exhibit 99 ACADIA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS COMPANY PROVIDES FULL YEAR AND FIRST QUARTER 2025 GUIDANCE, ANNOUNCES $300 MILLION SHARE REPURCHASE AUTHORIZATION FRANKLIN, Tenn.
February 18, 2025	CORRESP	ANNEX A (Responsive additions italicized and responsive deletions indicated with strikethrough) Acadia Healthcare Company, Inc. Operating Statistics (1) (Unaudited, Revenue $ in thousands except per Patient Day metrics) Three Months Ended September 3 February 18, 2025 VIA EDGAR Tayyaba Shafique Tracey Houser Division of Corporation Finance Office of Industrial Applications and Services United States Securities and Exchange Commission 100 F Street, NE Washington, D.
January 21, 2025	CORRESP	* * * * January 21, 2025 VIA EDGAR Tayyaba Shafique Tracey Houser Division of Corporation Finance Office of Industrial Applications and Services United States Securities and Exchange Commission 100 F Street, NE Washington, D.
January 13, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 13, 2025 Acadia Healthcare Company, Inc.
December 23, 2024	CORRESP	[Signature Page Follows] December 23, 2024 VIA EDGAR Tayyaba Shafique Tracey Houser Division of Corporation Finance Office of Industrial Applications and Services United States Securities and Exchange Commission 100 F Street, NE Washington, D.
December 6, 2024	CORRESP	ANNEX A (Responsive changes italicized) Acadia Healthcare Company, Inc. Operating Statistics (Unaudited, Revenue in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 % Change 2024 2023 % Change Same Facility Result CORRESP December 6, 2024 VIA EDGAR Tayyaba Shafique Tracey Houser Division of Corporation Finance Office of Industrial Applications and Services United States Securities and Exchange Commission 100 F Street, NE Washington, D.
November 25, 2024	CORRESP	[Signature Page Follows] November 25, 2024 VIA EDGAR Tayyaba Shafique Tracey Houser Division of Corporation Finance Office of Industrial Applications and Services United States Securities and Exchange Commission 100 F Street, NE Washington, D.
November 8, 2024	EX-99	JOINT FILING AGREEMENT EX-99 2 Rule13DJointFilingAgreement.htm JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Acadia Healthcare Company, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of
November 8, 2024	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appr
October 30, 2024	8-K	Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2024 (October 30, 2024) Acadia Healthcare Company, Inc.
October 30, 2024	EX-99	ACADIA HEALTHCARE REPORTS STRONG THIRD QUARTER 2024 RESULTS PROVIDES UPDATED GUIDANCE FOR 2024 Exhibit 99 ACADIA HEALTHCARE REPORTS STRONG THIRD QUARTER 2024 RESULTS PROVIDES UPDATED GUIDANCE FOR 2024 FRANKLIN, Tenn.
October 30, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadi
September 27, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 27, 2024 (September 27, 2024) Acadia Healthcare Company, Inc.
August 1, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadia Hea
July 31, 2024	EX-99	ACADIA HEALTHCARE REPORTS SECOND QUARTER 2024 RESULTS PROVIDES UPDATED GUIDANCE FOR 2024 Exhibit 99 ACADIA HEALTHCARE REPORTS SECOND QUARTER 2024 RESULTS PROVIDES UPDATED GUIDANCE FOR 2024 FRANKLIN, Tenn.
July 31, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2024 (July 31, 2024) Acadia Healthcare Company, Inc.
June 6, 2024	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) May 31, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
May 24, 2024	EX-10.1	Employment Agreement, dated as of May 23, 2024, by and between Acadia Management Company, Inc. and Dr. Nasser Khan EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of May 23, 2024 (the “Effective Date”), by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and Nasser Khan (“Executive”). WHEREAS, the Company desires to continue to employ Executive, and Executive desires to continue to be employed by and render s
May 24, 2024	EX-10.2	Separation and Consulting Agreement, dated May 23, 2024, between Acadia Management Company, LLC and John S. Hollinsworth EX-10.2 Exhibit 10.2 SEPARATION AND CONSULTING AGREEMENT This Separation Agreement (this “Agreement”), dated May 23, 2024, is effective as of the “Effective Date” (as defined below), between Acadia Management Company, Inc. (the “Company”) and John Hollinsworth (“Employee” and with the Company, collectively, the “Parties”). W I T N E S S E T H WHEREAS, Employee is employed by the Company pursuant t
May 24, 2024	EX-3.1	Amended and Restated Certificate of Incorporation, as amended Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ACADIA HEALTHCARE COMPANY, INC. ACADIA HEALTHCARE COMPANY, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify: FIRST: The name of the Corporation is Acadia Healthcare Company, Inc. SECOND: The Amended and Restat
May 24, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 23, 2024 Acadia Healthcare Comp UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 23, 2024 Acadia Healthcare Company, Inc.
May 2, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadia He
May 1, 2024	EX-99	ACADIA HEALTHCARE REPORTS FIRST QUARTER 2024 RESULTS, AFFIRMS FULL YEAR 2024 GUIDANCE Exhibit 99 ACADIA HEALTHCARE REPORTS FIRST QUARTER 2024 RESULTS, AFFIRMS FULL YEAR 2024 GUIDANCE FRANKLIN, Tenn.
May 1, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2024 (May 1, 2024) Acadia Healthcare Company, Inc.
April 9, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 9, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 28, 2024	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 28, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 ACADIA HEALTHC
February 28, 2024	EX-97	Acadia Healthcare Company, Inc. Policy Regarding the Mandatory Recovery of Compensation Exhibit 97 ACADIA HEALTHCARE COMPANY, INC. RESOLUTIONS OF THE BOARD OF DIRECTORS October 26, 2023 WHEREAS, in response to the U.S. Securities and Exchange Commission’s adoption of Rule 10D-1 of the Securities Exchange Act of 1934, the Nasdaq Stock Market adopted a new listing standard which requires listed companies to adopt and implement a policy for the recovery of incentive-based compensation r
February 28, 2024	EX-21	Subsidiaries of the Company Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Delaware Acadia Assurance Company Acadia Battle Creek Holdings, LLC Acadia Central Florida JV Holdings, LLC Tennessee Tennessee Delaware Acadia Chattanooga Holdings, LLC Tenne
February 28, 2024	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of December 31, 2023, guarantors of the Company’s 5.
February 27, 2024	EX-99	ACADIA HEALTHCARE REPORTS FOURTH QUARTER 2023 RESULTS COMPANY PROVIDES FULL YEAR AND FIRST QUARTER 2024 GUIDANCE Exhibit 99 Contact: Gretchen Hommrich Vice President, Investor Relations (615) 861-6000 ACADIA HEALTHCARE REPORTS FOURTH QUARTER 2023 RESULTS COMPANY PROVIDES FULL YEAR AND FIRST QUARTER 2024 GUIDANCE FRANKLIN, Tenn.
February 27, 2024	8-K	Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2024 (February 27, 2024) Acadia Healthcare Company, Inc.
February 13, 2024	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0168-acadiahealthcarecoinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Acadia Healthcare Co Inc Title of Class of Securities: Common Stock CUSIP Number: 00404A109 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box t
February 9, 2024	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Acadia Healthcare Co Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
February 8, 2024	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the approp
January 19, 2024	EX-10.1	Amendment No. 2 to Credit Agreement, dated as of January 18, 2024, by and among the Company, certain subsidiaries of the Company, as guarantors, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and Bank of America, N.A., as Administrative Agent and Swingline Lender EXHIBIT 10.1 AMENDMENT NO. 2 TO CREDIT AGREEMENT This AMENDMENT NO. 2 To Credit Agreement (this “Amendment”) dated as of January 18, 2024, between ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation (the “Borrower”), the LENDERS party hereto, Capital One, National Association, Citibank, N.A., Credit Agricole Corporate and Investment Bank, Fifth Third Bank, National Association, JPMorgan Chase
January 19, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2024 Acadia Healthcare Company, Inc.
November 3, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadi
November 2, 2023	EX-99	Acadia Healthcare Reports Third Quarter 2023 Results and Updates Guidance Ranges to Reflect Continued Strong Business Growth and Momentum Exhibit 99 Acadia Healthcare Reports Third Quarter 2023 Results and Updates Guidance Ranges to Reflect Continued Strong Business Growth and Momentum Same Facility Revenue Increases 13% FRANKLIN, Tenn.
November 2, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2023 Acadia Healthcare Company, Inc.
October 30, 2023	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2023 (October 30, 2023) Acadia Healthcare Company, Inc.
October 30, 2023	EX-10.2	Settlement Agreement, Release in Full and Indemnification Agreement, dated October 30, 2023, by and among Acadia Healthcare Company, Inc., Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills, and Feliz Rael, as Guardian Ad Litem EX-10.2 Exhibit 10.2 SETTLEMENT AGREEMENT, RELEASE IN FULL AND INDEMNIFICATION AGREEMENT I. PARTIES The Parties to this Agreement are Feliz Rael, as Guardian Ad Litem for and on behalf of (M.M.), individually, Acadia Healthcare Company, Inc. (“Acadia”), and Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills (“Desert Hills”). II. DEFINITIONS In this Agreement, te
October 30, 2023	EX-10.3	Settlement Agreement, Release in Full and Indemnification Agreement, dated October 30, 2023, by and among Acadia Healthcare Company, Inc., Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills, and Alison Endicott-Quiñones, as Guardian Ad Litem Exhibit 10.3 SETTLEMENT AGREEMENT, RELEASE IN FULL AND INDEMNIFICATION AGREEMENT I. PARTIES The Parties to this Agreement are Alison Endicott-Quiñones, as Guardian ad litem of (“L.D.”), a minor child, Acadia Healthcare Company, Inc. (“Acadia”), and Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills (“Desert Hills”). II. DEFINITIONS In this Agreement, terms that appear
October 30, 2023	EX-10.1	Settlement Agreement, Release in Full and Indemnification Agreement, dated October 30, 2023, by and among Acadia Healthcare Company, Inc., Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills, and Shasta N. Inman, as Guardian Ad Litem EX-10.1 Exhibit 10.1 SETTLEMENT AGREEMENT, RELEASE IN FULL AND INDEMNIFICATION AGREEMENT I. PARTIES The Parties to this Agreement are Shasta N. Inman, as Guardian Ad Litem for and on behalf of (G.S.), a minor, Acadia Healthcare Company, Inc. (“Acadia”), and Youth and Family Centered Services of New Mexico, Inc. d/b/a Desert Hills (“Desert Hills”). II. DEFINITIONS In this Agreement, terms tha
October 26, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 26, 2023 Acadia Healthcare Company, Inc.
October 26, 2023	EX-99	ACADIA HEALTHCARE WELCOMES DR. PATRICE A. HARRIS, MD, MA AS INDEPENDENT DIRECTOR Former President of the American Medical Association and Board-Certified Psychiatrist Adds Significant Mental Health and Substance Abuse Clinical Expertise Exhibit 99 Contact: Gretchen Hommrich Vice President, Investor Relations (615) 861-6000 ACADIA HEALTHCARE WELCOMES DR.
October 11, 2023	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 11, 2023 (October 11, 2023) Acadia Healthcare Company, Inc.
July 28, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadia Hea
July 28, 2023	EX-10.2	Employment Agreement, dated June 30, 2023, by and between Acadia Management Company, Inc. and Brian Farley Exhibit 10.2 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2023 (the “Effective Date”), by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and Brian Farley (“Executive”). WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by and render services to the Company and its
July 28, 2023	EX-10.3	First Amendment to Employment Agreement, dated July 6, 2023, by and between Acadia Management Company, Inc. and Brian Farley, dated as of June 30, 2023 Exhibit 10.3 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT, dated effective as of July 6, 2023 (this “Agreement”), is by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and Brian Farley (“Executive”). WHEREAS, the Company and Executive are party to that certain Employment Agreement, dated as of June 30, 2023 (the “Employme
July 27, 2023	EX-99	Acadia Healthcare Reports Second Quarter 2023 Results and Raises 2023 Guidance Exhibit 99 Acadia Healthcare Reports Second Quarter 2023 Results and Raises 2023 Guidance Company Signs Definitive Agreement for Acquisition of Specialty Provider FRANKLIN, Tenn.
July 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 27, 2023 (July 27, 2023) Acadi UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 27, 2023 (July 27, 2023) Acadia Healthcare Company, Inc.
July 11, 2023	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 11, 2023 Acadia Healthcare Company, Inc.
July 5, 2023	EX-10.2	Transition Agreement, dated July 5, 2023, by and between Acadia Management Company, LLC and David Duckworth. (3) EX-10.2 Exhibit 10.2 EXECUTION VERSION TRANSITION AGREEMENT This Transition Agreement (“Agreement”) by and between Acadia Management Company, LLC (the “Company”) and David Duckworth (“Executive”), and for the purposes of Section 4 only, Acadia Healthcare Company, Inc. (“Acadia”), is entered into and effective as of July 5, 2023. WHEREAS, the Company and Executive are parties to an Employment Agree
July 5, 2023	EX-10.3	Separation and Consulting Agreement, dated June 28, 2023 between Acadia Management Company, LLC and Laurence Harrod. (3) EX-10.3 Exhibit 10.3 Execution Version SEPARATION AND CONSULTING AGREEMENT This Separation Agreement (this “Agreement”), dated June 28, 2023, is effective as of the “Effective Date” (as defined below), between Acadia Management Company, Inc. (the “Company”) and Laurence Harrod (“Employee” and with the Company, collectively, the “Parties”). W I T N E S S E T H WHEREAS, Employee is employed by the C
July 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 5, 2023 (June 28, 2023) Acadia UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 5, 2023 (June 28, 2023) Acadia Healthcare Company, Inc.
July 5, 2023	EX-10.1	Separation and Transition Agreement, dated July 5, 2023 between Acadia Management Company, LLC. and Chris Howard. (3) EX-10.1 Exhibit 10.1 Execution Version SEPARATION AND TRANSITION AGREEMENT This Separation Agreement (this “Agreement”), dated July 5, 2023, is effective as of the “Effective Date” (as defined below), between Acadia Management Company, LLC (the “Company”) and Chris Howard (“Employee”), and for the purposes of Section 3 only, Acadia Healthcare Company, Inc. (“Acadia” and with the Company and Employ
June 2, 2023	EX-99.1	ACADIA HEALTHCARE APPOINTS HEATHER DIXON AS CHIEF FINANCIAL OFFICER Dixon Brings Over 25 Years of Financial and Healthcare Experience David Duckworth to Step Down After 12 Years as Acadia’s CFO Larry Harrod, EVP, Finance Announces Retirement; Tim Sid EX-99.1 Exhibit 99.1 Contact: Gretchen Hommrich Vice President, Investor Relations (615) 861-6000 ACADIA HEALTHCARE APPOINTS HEATHER DIXON AS CHIEF FINANCIAL OFFICER Dixon Brings Over 25 Years of Financial and Healthcare Experience David Duckworth to Step Down After 12 Years as Acadia’s CFO Larry Harrod, EVP, Finance Announces Retirement; Tim Sides to Assume Responsibilities Company Reaffirms Full
June 2, 2023	EX-10.1	Employment Agreement, dated June 1, 2023, by and between Acadia Management Company, Inc. and Heather B. Dixon EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of June 1, 2023, by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and Heather Dixon (“Executive”). WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by and render services to the Company and its respective aff
June 2, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 2, 2023 (June 1, 2023) Acadia UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 2, 2023 (June 1, 2023) Acadia Healthcare Company, Inc.
May 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2023 (May 18, 2023) Acadia UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2023 (May 18, 2023) Acadia Healthcare Company, Inc.
April 27, 2023	EX-10	Amendment No. 1 to Credit Agreement, dated as of March 30, 2023, by and among the Company, certain subsidiaries of the Company, as guarantors, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and Bank of America, N.A., as Administrative Agent and Swingline Lender Exhibit 10.1 AMENDMENT NO. 1 This AMENDMENT NO. 1 (this “Amendment”), dated as of March 30, 2023, between ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation (the “Borrower”), the LENDERS party hereto and BANK OF AMERICA, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”), as the Swing Line Lender (in such capacity, the “Swing Line Lender”) and as an L/C Issuer (in su
April 27, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 Acadia He
April 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 26, 2023 Acadia Healthcare Co UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 26, 2023 Acadia Healthcare Company, Inc.
April 26, 2023	EX-99	Acadia Healthcare Reports First Quarter 2023 Results Exhibit 99 Acadia Healthcare Reports First Quarter 2023 Results Company Affirms Full Year 2023 Guidance FRANKLIN, Tenn.
April 7, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 7, 2023	DEF 14A	Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan (a) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 28, 2023	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities. (4) Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of December 31, 2022, guarantors of the Company’s 5.
February 28, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
February 28, 2023	EX-21	Subsidiaries of the Company. Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Delaware Acadia Assurance Company Acadia Battle Creek Holdings, LLC Acadia Central Florida JV Holdings, LLC Tennessee Tennessee Delaware Acadia Chattanooga Holdings, LLC Tenne
February 27, 2023	EX-99	Acadia Healthcare Reports Fourth Quarter 2022 Results Exhibit 99 Acadia Healthcare Reports Fourth Quarter 2022 Results Company Provides Full Year and First Quarter 2023 Guidance FRANKLIN, Tenn.
February 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2023 (February 27, 202 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2023 (February 27, 2023) Acadia Healthcare Company, Inc.
February 10, 2023	SC 13G/A	ACHC / Acadia Healthcare Company Inc / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Acadia Healthcare Co Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
February 9, 2023	SC 13G/A	ACHC / Acadia Healthcare Company Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0150-acadiahealthcarecoinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Acadia Healthcare Co. Inc. Title of Class of Securities: Common Stock CUSIP Number: 00404A109 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box
February 6, 2023	SC 13G/A	ACHC / Acadia Healthcare Company Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the approp
December 7, 2022	EX-99.1	Acadia Healthcare Provides Business Outlook Ahead of Investor Day Exhibit 99.1 Acadia Healthcare Provides Business Outlook Ahead of Investor Day FRANKLIN, Tenn.-(BUSINESS WIRE)-December 7, 2022-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) will host its first Investor Day beginning at approximately 9:00 a.m. Eastern Time today, Wednesday, December 7, 2022, in New York City. During the event, members of Acadia’s management team will provide an overview of the Co
December 7, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 7, 2022 (December 7, 2022) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 7, 2022 (December 7, 2022) Acadia Healthcare Company, Inc.
November 2, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
November 1, 2022	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.
November 1, 2022	EX-99.1	CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results Exhibit 99.1 CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results Same Facility Revenue Increases 10.2% CORRECTION...by Acadia Healthcare Company, Inc. FRANKLIN, Tenn.-(BUSINESS WIRE)-October 31, 2022-There was an inadvertent error on the supplementary table titled “Reconciliation of Net Income Attributable to Acadia Healthcare Company, Inc. to Adjusted Income Attributable
October 31, 2022	EX-99	Acadia Healthcare Reports Third Quarter 2022 Results Exhibit 99 Acadia Healthcare Reports Third Quarter 2022 Results Same Facility Revenue Increases 10.
October 31, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2022 (October 31, 2022) Acadia Healthcare Company, Inc.
July 28, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00
July 27, 2022	EX-99	Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance Exhibit 99 Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance FRANKLIN, Tenn.
July 27, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 27, 2022 (July 27, 2022) Acadia Healthcare Company, Inc.
June 29, 2022	EX-99	Acadia Healthcare Names R. David Kelly to Board of Directors Exhibit 99 Acadia Healthcare Names R. David Kelly to Board of Directors Adds Financial Advisory and Real Estate Development Experience to Acadia Board FRANKLIN, Tenn.? Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that R. David Kelly has been appointed to serve as an independent director on the Company?s Board of Directors. Kelly brings over 35 years of investment experience to Ac
June 29, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 29, 2022 (June 28, 2022) Acadia Healthcare Company, Inc.
May 20, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2022 Acadia Healthcare Company, Inc.
May 18, 2022	DEFA14A	UNITED STATES DEFA14A 1 brhc10037876defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Con
May 12, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
May 4, 2022	EX-10.3	Employment Agreement, dated March 31, 2022, by and among the Company, Acadia Management Company, Inc. and Christopher H. Hunter Exhibit 10.3 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is made and entered into as of March 31, 2022 by and between Acadia Management Company, LLC, a Delaware limited liability company (the ?Company?), Christopher H. Hunter (?Executive?). Acadia Healthcare Company, Inc., a Delaware corporation (?Acadia?) shall be a party to the Agreement only to the extent expressly set for
May 4, 2022	EX-10.2	Consultant Services Agreement, dated April 11, 2022, by and between Acadia Management Company, Inc. and Debra K. Osteen Exhibit 10.2 CONSULTANT SERVICES AGREEMENT This Consultant Services Agreement ("Agreement") by and between Acadia Management Company, LLC (the ?Company?) and Debbie Osteen (?Consultant?), is entered into and effective as of April 11, 2022 (the ?Commencement Date?). WHEREAS, Consultant is a member of the board of directors (the ?Board?) and the former Chief Executive Officer of Acadia Healthcare Co
May 4, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0
May 3, 2022	EX-99	Acadia Healthcare Reports First Quarter 2022 Results Exhibit 99 Acadia Healthcare Reports First Quarter 2022 Results FRANKLIN, Tenn.-(BUSINESS WIRE)-May 3, 2022-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2022. First Quarter Highlights Revenue totaled $616.7 million, an increase of 11.9% over the first quarter of 2021 Same facility revenue increased 8.6% compared to the first
May 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 3, 2022 Acadia Healthcare Company, Inc.
April 8, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 8, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 4, 2022	EX-99.1	Acadia Healthcare Announces Christopher Hunter as New Chief Executive Officer Exhibit 99.1 Acadia Healthcare Announces Christopher Hunter as New Chief Executive Officer FRANKLIN, Tenn.-(BUSINESS WIRE)-April 1, 2022-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that its Board of Directors has named Christopher Hunter as the Company?s new Chief Executive Officer. He will join Acadia on April 11, 2022 and will serve on the Company?s Board of Directors. Hunter
April 4, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 31, 2022 Acadia Healthcare Company, Inc.
March 1, 2022	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities. Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of December 31, 2021, guarantors of the Company?s 5.
March 1, 2022	EX-21	Subsidiaries of the Company. Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Delaware Acadia Assurance Company Acadia Battle Creek Holdings, LLC Acadia Central Florida JV Holdings, LLC Tennessee Tennessee Delaware Acadia Chattanooga Holdings, LLC Tenne
March 1, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
February 28, 2022	EX-99	Acadia Healthcare Reports Fourth Quarter 2021 Results Exhibit 99 Acadia Healthcare Reports Fourth Quarter 2021 Results Company Provides Full Year and First Quarter 2022 Guidance FRANKLIN, Tenn.
February 28, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 28, 2022 Acadia Healthcare Company, Inc.
February 9, 2022	SC 13G/A	ACHC / Acadia Healthcare Company Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Acadia Healthcare Co. Inc. Title of Class of Securities: Common Stock CUSIP Number: 00404A109 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is f
February 8, 2022	SC 13G/A	ACHC / Acadia Healthcare Company Inc / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Acadia Healthcare Co Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
February 4, 2022	SC 13G/A	ACHC / Acadia Healthcare Company Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
February 1, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 31, 2022 Acadia Healthcare Company, Inc.
February 1, 2022	EX-10.2	Side Letter to Employment Agreement, dated January 31, 2022, by and between Acadia Management Company, Inc. and Debra K. Osteen Exhibit 10.2 SIDE LETTER TO EMPLOYMENT AGREEMENT Acadia Management Company, Inc., a Delaware corporation (the ?Company?), and Debra K. Osteen (the ?Executive?) hereby acknowledge and agree that that certain Employment Agreement, dated as of January 19, 2021, as amended on December 22, 2021(as amended, the ?Employment Agreement?), shall remain in effect until March 31, 2022 or until such time it is
February 1, 2022	EX-10.1	Amendment to Employment Agreement, dated December 22, 2021, by and between Acadia Management Company, Inc. and Debra K. Osteen Exhibit 10.1 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT TO EMPLOYMENT AGREEMENT, effective as of December 22, 2021 the ?Agreement?), is by and between Acadia Management Company, Inc., a Delaware corporation (the ?Company?), and Debra K. Osteen (the ?Executive?). WHEREAS, the Company and Executive are party to that certain Employment Agreement, dated as of January 19, 2021 (the ?Employment Ag
October 29, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
October 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2021 Acadia Healthcare Company, Inc.
October 28, 2021	EX-99	Acadia Healthcare Reports Third Quarter 2021 Results Exhibit 99 Acadia Healthcare Reports Third Quarter 2021 Results Same Facility Revenue Grows 7.
October 5, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 5, 2021 Acadia Healthcare Company, Inc.
October 5, 2021	EX-99.1	Acadia Healthcare Announces Retirement of Chief Executive Officer Exhibit 99.1 Acadia Healthcare Announces Retirement of Chief Executive Officer FRANKLIN, Tenn.-(BUSINESS WIRE)-October 5, 2021-The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia?s Board of Directors and will assist in the selection and transition of the new CEO. It is anticipate
August 3, 2021	S-8	As filed with the Securities and Exchange Commission on August 3, 2021 As filed with the Securities and Exchange Commission on August 3, 2021 Registration No.
August 3, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00
August 2, 2021	EX-99	Acadia Healthcare Reports Second Quarter 2021 Results and Increases 2021 Guidance Exhibit 99 Acadia Healthcare Reports Second Quarter 2021 Results and Increases 2021 Guidance FRANKLIN, Tenn.
August 2, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 2, 2021 (August 2, 2021) Acadia Healthcare Company, Inc.
May 7, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2021 Acadia Healthcare Company, Inc.
April 30, 2021	10-Q	Quarterly Report - 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0
April 30, 2021	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities. Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of March 31, 2021, guarantors of the Company?s 5.
April 29, 2021	EX-99	Acadia Healthcare Reports First Quarter 2021 Results and Increases 2021 Guidance Exhibit 99 Acadia Healthcare Reports First Quarter 2021 Results and Increases 2021 Guidance Revenue Grows 8.
April 29, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2021 Acadia Healthcare Company, Inc.
March 24, 2021	DEF 14A	Second Amendment, effective May 6, 2021, to the Acadia Healthcare Company, Inc. Incentive Compensation Plan. (r) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 24, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 22, 2021	EX-10.2	Security and Pledge Agreement, dated as of March 17, 2021, among the Company, the other obligors party thereto and Bank of America, N.A., as Administrative Agent. (j) Exhibit 10.2 SECURITY AND PLEDGE AGREEMENT THIS SECURITY AND PLEDGE AGREEMENT (this ?Agreement?) is entered into as of March 17, 2021 among the parties identified as ?Obligors? on the signature pages hereto and such other parties that may become Obligors hereunder after the date hereof (each individually an ?Obligor? and collectively the ?Obligors?), and BANK OF AMERICA, N.A., in its capacity as a
March 22, 2021	EX-10.1	Credit Agreement, dated as of March 17, 2021, among the Company, certain subsidiaries of the Company, as guarantors, the several banks and other financial institutions as may from time to time become parties thereunder as lenders, and Bank of America, N.A., as Administrative Agent and Swingline Lender. (j) Exhibit 10.1 CREDIT AGREEMENT Dated as of March 17, 2021 among ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation, as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent and as the Swing Line Lender and an L/C Issuer, CAPITAL ONE, NATIONAL ASSOCIATION, CITIBANK, N.A., CR?DIT AGRICOLE CORPORATE AND INVESTMENT BANK, FIFTH THIRD BANK, NATIONAL ASSOCIATION, JPMORGAN CHASE BANK, N.A., TRU
March 22, 2021	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2021 Acadia Healthcare Company, Inc.
February 26, 2021	EX-2.1	Put and Call Option Deed, dated as of December 30, 2020, by and between RemedcoUK Limited and the Company Exhibit 2.1 RemedcoUK Limited 1 Bartholomew Lane London United Kingdom EC2N 2AX (the ?Purchaser?, ?we? or ?us?) Acadia Healthcare Company Inc. 6100 Tower Circle Suite 1000 Franklin, Tennessee 37067 USA (the ?Seller?) STRICTLY PRIVATE AND CONFIDENTIAL Project Prince ? Put and Call Option Deed Dear Sirs, We refer to our discussions relating to the contemplated acquisition by us of all the securities
February 26, 2021	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of December 31, 2020, guarantors of the Company?s 5.
February 26, 2021	EX-21	Subsidiaries of the Company Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Delaware Acadia Assurance Company Tennessee Acadia Chattanooga Holdings, LLC Tennessee Acadia Columbus JV Holdings, LLC Delaware Acadia Crestwyn Holdings, LLC Acadia CTC Holdi
February 26, 2021	10-K	Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
February 26, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 25, 2021 (February 25, 2021) Acadia Healthcare Company, Inc.
February 26, 2021	EX-99	Acadia Healthcare Reports Fourth Quarter 2020 Results Exhibit 99 Acadia Healthcare Reports Fourth Quarter 2020 Results Company Provides Full Year and First Quarter 2021 Guidance Expects to Complete Debt Refinancing in March 2021 FRANKLIN, Tenn.
February 26, 2021	EX-4.13	Description of the Company’s Securities Exhibit 4.13 DESCRIPTION OF THE COMPANY?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Acadia Healthcare Company, Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, $0.01 par value per share. In this exhibit, when we refer to ?Acadia,? the ?Company,? ?we,? ?us? or ?our? or when we
February 26, 2021	EX-2.2	Share Purchase Agreement, dated as of January 7, 2021, by and between RemedcoUK Limited and the Company Exhibit 2.2 Date: 7 January 2021 share purchase AGREEMENT relating to AHC - WW JERSEY LIMITED between ACADIA HEALTHCARE COMPANY INC (AS SELLER) and REMEDCOUK LIMITED (as Purchaser) KIRKLAND & ELLIS INTERNATIONAL LLP 30 St. Mary Axe London EC3A 8AF Tel: +44 (0)20 7469 2000 Fax: +44 (0)20 7469 2001 www.kirkland.com Table of Contents Page 1 Definitions and interpretation5 2 Sale and purchase14 3 Cons
February 12, 2021	SC 13G/A	SCHEDULE 13G SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Acadia Healthcare Co Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Acadia Healthcare Co. Inc. Title of Class of Securities: Common Stock CUSIP Number: 00404A109 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is f
February 3, 2021	SC 13G/A	SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
January 22, 2021	EX-10.1	Employment Agreement, dated as of January 19, 2021, by and between Acadia Management Company, Inc. and Debra K. Osteen EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of January 19, 2021 by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and Debra K. Osteen (“Executive”). WHEREAS, the Company and the Executive are a party to that certain Employment Agreement, dated as of December 16, 2018 (the “Original Employme
January 22, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 19, 2021 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (C
January 21, 2021	EX-99.1	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION EX-99.1 2 d56330dex991.htm EX-99.1 Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The tables below set forth the unaudited pro forma condensed combined financial data for Acadia Healthcare Company, Inc. (the “Company”) giving effect to the Company’s disposition of AHC-WW Jersey Limited (the “U.K. Divestiture”), a private limited liability company incorporated in Jersey a
January 21, 2021	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 19, 2021 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (C
January 7, 2021	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2021 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (Co
December 30, 2020	EX-99.1	ACADIA HEALTHCARE ANNOUNCES DEFINITIVE AGREEMENT TO SELL U.K. OPERATIONS EX-99.1 Exhibit 99.1 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE ANNOUNCES DEFINITIVE AGREEMENT TO SELL U.K. OPERATIONS FRANKLIN, Tenn. (December 30, 2020) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced that it has entered into a definitive agreement to sell its U.K. operations to Waterland Private Equity (“
December 30, 2020	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 30, 2020 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (
December 11, 2020	SC 13D/A	ACHC / Acadia Healthcare Company, Inc. / P2 Capital Partners, LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 00404A109 (CUSIP Number) Jason Carri P2 Capital Partners, LLC 590 Madison Avenue 25th Floor New York, NY 10022 (212) 508-5500 (Name, Address and
November 13, 2020	EX-10.1	Fourth Refinancing Facilities Amendment, dated November 13, 2020, to the Amended and Restated Credit Agreement, dated December 31, 2012 (as amended, restated or otherwise modified to date), by and among Bank of America, NA (Administrative Agent, Swing Line Lender and L/C Issuer), the Company, the guarantors listed on the signature pages thereto, and the lenders listed on the signature pages thereto. EX-10.1 2 d88327dex101.htm EX-10.1 Exhibit 10.1 Execution Version Published CUSIP Number: [ ] Deal: 00404DAA1 FOURTH REFINANCING FACILITIES AMENDMENT Dated as of November 13, 2020 to the AMENDED AND RESTATED CREDIT AGREEMENT Dated as of December 31, 2012 among ACADIA HEALTHCARE COMPANY, INC., as the Borrower, ITS SUBSIDIARIES IDENTIFIED HEREIN, as the Guarantors, BANK OF AMERICA, N.A., as Administ
November 13, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 13, 2020 Acadia Healthcare Company, Inc.
November 9, 2020	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / JPMORGAN CHASE & CO - FILING ACADIA HEALTHCARE COMPANY, INC. Passive Investment SC 13G/A 1 AcadiaHealthcareCompany.htm FILING ACADIA HEALTHCARE COMPANY, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 06)* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 00404A109 (CUSIP Number) October 30, 2020 (Date of Event Which Req
October 30, 2020	10-Q	Quarterly Report - 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
October 30, 2020	EX-22	List of Subsidiary Guarantors and Issuers of Guaranteed Securities Exhibit 22 List of Guarantor Subsidiaries The following subsidiaries of the Company were, as of September 30, 2020, guarantors of the Company’s 5.
October 29, 2020	EX-99	Acadia Healthcare Reports Third Quarter 2020 Results Exhibit 99 Acadia Healthcare Reports Third Quarter 2020 Results Company Provides Fourth Quarter 2020 Guidance FRANKLIN, Tenn.
October 29, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - ACADIA HEALTHCARE COMPANY, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 29, 2020 (October 29, 2020) Acadia Healthcare Company, Inc.
October 28, 2020	EX-99	ACADIA HEALTHCARE NAMES FORMER DELOITTE U.S. CHAIRMAN MICHAEL J. FUCCI TO BOARD OF DIRECTORS Adds Risk Management and Human Resource Expertise to Acadia Board EX-99 Exhibit 99 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE NAMES FORMER DELOITTE U.
October 28, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2020 (October 22, 2020) Acadia Healthcare Company, Inc.
October 14, 2020	EX-4.1	Indenture, dated October 14, 2020, by and among the Company, the guarantors party thereto and U.S. Bank National Association, as Trustee EX-4.1 Exhibit 4.1 ACADIA HEALTHCARE COMPANY, INC. AND EACH OF THE GUARANTORS PARTY HERETO $475,000,000 5.000% SENIOR NOTES DUE 2029 INDENTURE Dated as of October 14, 2020 U.S. BANK NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 47 Section 1.03. Inapplicability of Trust Indentu
October 14, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 14, 2020 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (C
October 8, 2020	CORRESP	October 8, 2020 October 8, 2020 Via EDGAR Submission Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.
September 29, 2020	8-K	Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 29, 2020 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation)
September 29, 2020	EX-99.3	ACADIA HEALTHCARE PROVIDES AN UPDATE ON THE U.K. SALE PROCESS EX-99.3 Exhibit 99.3 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE PROVIDES AN UPDATE ON THE U.K. SALE PROCESS FRANKLIN, Tenn. (September 29, 2020) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) today provides an update on the sale process for the U.K. business. The Company previously suspended the sale process due to the mar
September 29, 2020	EX-99.1	ACADIA HEALTHCARE ANNOUNCES LAUNCH OF $475 MILLION SENIOR NOTES OFFERING EX-99.1 2 d79250dex991.htm EX-99.1 Exhibit 99.1 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE ANNOUNCES LAUNCH OF $475 MILLION SENIOR NOTES OFFERING FRANKLIN, Tenn. (September 29, 2020) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of senior notes due 2
September 29, 2020	EX-99.2	ACADIA HEALTHCARE ANNOUNCES PRICING OF $475 MILLION SENIOR NOTES DUE EX-99.2 3 d79250dex992.htm EX-99.2 Exhibit 99.2 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE ANNOUNCES PRICING OF $475 MILLION SENIOR NOTES DUE 2029 FRANKLIN, Tenn. (September 29, 2020) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its previously announced private offering (the “Offering”) of
August 5, 2020	10-Q	Quarterly Report - ACHC-10-Q-20200630 Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00
August 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2020 (August 4, 2020) Acadia Healthcare Company, Inc.
August 4, 2020	EX-99	Acadia Healthcare Reports Second Quarter 2020 Results Exhibit 99 Acadia Healthcare Reports Second Quarter 2020 Results FRANKLIN, Tenn.-(BUSINESS WIRE)-August 4, 2020-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2020. The Company reported revenue of $750.3 million for the second quarter of 2020, compared with $789.4 million for the second quarter of 2019. Net income attributable
June 24, 2020	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 24, 2020 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (Comm
June 24, 2020	EX-4.1	Indenture, dated June 24, 2020, by and among the Company, the guarantors party thereto and U.S. Bank National Association, as Trustee EX-4.1 Exhibit 4.1 ACADIA HEALTHCARE COMPANY, INC. AND EACH OF THE GUARANTORS PARTY HERETO $450,000,000 5.500% SENIOR NOTES DUE 2028 INDENTURE Dated as of June 24, 2020 U.S. BANK NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 47 Section 1.03. Inapplicability of Trust Indenture
June 10, 2020	EX-99.2	ACADIA HEALTHCARE ANNOUNCES PRICING OF $450 MILLION SENIOR NOTES DUE 2028 AND INTENTION TO REDEEM ITS 2021 NOTES AND 2022 NOTES EX-99.2 Exhibit 99.2 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE ANNOUNCES PRICING OF $450 MILLION SENIOR NOTES DUE 2028 AND INTENTION TO REDEEM ITS 2021 NOTES AND 2022 NOTES FRANKLIN, Tenn. (June 10, 2020) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its previously announced private offerin
June 10, 2020	EX-99.1	ACADIA HEALTHCARE ANNOUNCES LAUNCH OF $450 MILLION SENIOR NOTES OFFERING EX-99.1 Exhibit 99.1 Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000 ACADIA HEALTHCARE ANNOUNCES LAUNCH OF $450 MILLION SENIOR NOTES OFFERING FRANKLIN, Tenn. (June 10, 2020) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of senior notes due 2028 (the “Notes”), subject to cu
June 10, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 10, 2020 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or other jurisdiction of incorporation) (Comm
May 8, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2020 Acadia Healthcare Company, Inc.
May 5, 2020	10-Q	Quarterly Report - 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0
May 4, 2020	EX-99	Acadia Healthcare Reports First Quarter 2020 Results Exhibit 99 Acadia Healthcare Reports First Quarter 2020 Results Withdraws Full-Year 2020 Guidance Due To COVID-19 Uncertainty FRANKLIN, Tenn.
May 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2020 Acadia Healthcare Company, Inc.
April 23, 2020	DEFA14A	- DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 22, 2020	EX-10	Thirteenth Amendment, dated April 1, 2020, to the Credit Agreement. (ii) EX-10 2 d913183dex10.htm EX-10 Exhibit 10 THIRTEENTH AMENDMENT THIS THIRTEENTH AMENDMENT (this “Amendment”) dated as of April 21, 2020 to the Credit Agreement referenced below is by and among ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation (the “Borrower”), the Guarantors identified on the signature pages hereto, the Lenders identified on the signature pages hereto and BANK OF AMERICA, N.A
April 22, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 21, 2020 Acadia Healthcare Company, Inc.
March 25, 2020	DEF 14A	ACHC / Acadia Healthcare Company, Inc. DEF 14A - - DEF 14A DEF 14A 1 d895717ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statem
March 25, 2020	DEFA14A	ACHC / Acadia Healthcare Company, Inc. DEFA14A - - DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 19, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 19, 2020 Acadia Healthcare Company, Inc.
March 19, 2020	EX-99	Acadia Healthcare Provides Business Update Exhibit 99 Acadia Healthcare Provides Business Update FRANKLIN, Tenn.-(BUSINESS WIRE)-March 19, 2020-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today provides a business update to investors in light of the ongoing market environment. Debbie Osteen, Chief Executive Officer of Acadia Healthcare Company, remarked, “Today, we face an unprecedented global event with the COVID-19 pandemic. Though we
February 28, 2020	10-K	Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
February 28, 2020	EX-21	Subsidiaries of the Company. Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Delaware Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Acadia Assurance Company Tennessee Acadia Chattanooga Holdings, LLC Tennessee Acadia Columbus JV Holdings, LLC Delaware Acadia Crestwyn Holdings, LLC Acadia Greenvill
February 28, 2020	EX-4.14	Description of the Company’s Securities. Exhibit 4.14 DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Acadia Healthcare Company, Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, $0.01 par value per share. In this exhibit, when we refer to “Acadia,” the “Company,” “we,” “us” or “our” or when we
February 27, 2020	EX-99	Acadia Healthcare Reports Fourth Quarter 2019 Results EX-99 2 a52181132ex99.htm EXHIBIT 99 Exhibit 99 Acadia Healthcare Reports Fourth Quarter 2019 Results Company Provides Full Year and First Quarter 2020 Guidance FRANKLIN, Tenn.-(BUSINESS WIRE)-February 27, 2020-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2019, that were in line with the Company’s previously iss
February 27, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2020 Acadia Healthcare Company, Inc.
February 14, 2020	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / Aristotle Capital Management, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* ACADIA HEALTHCARE COMPANY, INC. (Name of Issuer) Common Stock, Par Value of $0.01 Per Share (Title of Class of Securities) 00404A109 (CUSIP Number) Michel
February 12, 2020	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment SC 13G/A 1 dfs008.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ACADIA HEALTHCARE CO INC (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des
February 12, 2020	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Acadia Healthcare Co Inc Title of Class of Securities: Common Stock CUSIP Number: 00404A109 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is fil
January 28, 2020	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the approp
January 8, 2020	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / JP Morgan Chase & Co - FILING ACADIA HEALTHCARE COMPANY, INC. Passive Investment SC 13G/A 1 AcadiaHealthcareCompany.htm FILING ACADIA HEALTHCARE COMPANY, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 05)* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2019 (Date of Event Which Re
December 17, 2019	EX-99	Acadia Healthcare Names Senior Healthcare Investment Banker Jason Bernhard to Board of Directors EX-99 2 a52147989ex99.htm EXHIBIT 99 Exhibit 99 Acadia Healthcare Names Senior Healthcare Investment Banker Jason Bernhard to Board of Directors Adds Business, Financial and Capital Markets Expertise to Acadia Board FRANKLIN, Tenn.-(BUSINESS WIRE)-December 17, 2019-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Jason R. Bernhard has been appointed to serve as an independent di
December 17, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 13, 2019 Acadia Healthcare Company, Inc.
November 6, 2019	10-Q	Quarterly Report - 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
November 5, 2019	EX-99	Acadia Healthcare Reports Third Quarter 2019 Revenue of $777.3 Million, EPS of $0.48 and Adjusted EPS of $0.52 EX-99 2 a52123786ex99.htm EXHIBIT 99 Exhibit 99 Acadia Healthcare Reports Third Quarter 2019 Revenue of $777.3 Million, EPS of $0.48 and Adjusted EPS of $0.52 Company Updates 2019 Guidance FRANKLIN, Tenn.-(BUSINESS WIRE)-November 5, 2019-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the third quarter and nine months ended September 30, 2019. Revenue was $777.
November 5, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2019 (November 5, 2019) Acadia Healthcare Company, Inc.
September 20, 2019	EX-99.1	JOINT FILING AGREEMENT EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13D-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Shares of Common Stock, $.01 par value of Acadia Healthcare Company, Inc. and further agree to the filing of this agreement as an Exhib
September 20, 2019	SC 13D	ACHC / Acadia Healthcare Company, Inc. / P2 Capital Partners, LLC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 00404A109 (CUSIP Number) Jason Carri P2 Capital Partners, LLC 590 Madison Avenue 25th Floor New York, NY 10022 (212) 508-5500 (Name, Address and Telephone Number of
August 6, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 6, 2019 Acadia Healthcare Company, Inc.
August 6, 2019	EX-10	Employment Agreement, dated August 6, 2019, by and between Acadia Management Company, Inc. and Laurence L. Harrod EX-10 2 d774323dex10.htm EX-10 Exhibit 10 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of August 6, 2019, by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and Laurence Harrod (“Executive”). This Agreement shall become binding upon the execution hereof and shall be effective as of August 12, 2019 (the “Effective
August 6, 2019	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A Amendment No.
August 6, 2019	EX-10	Employment Agreement, dated July 31, 2019, by and between Acadia Management Company, Inc. and John S. Hollinsworth EX-10 2 d758371dex10.htm EX-10 Exhibit 10 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of July 31, 2019, by and between Acadia Management Company, Inc., a Delaware corporation (the “Company”), and John S. Hollinsworth (“Executive”). This Agreement shall become binding upon the execution hereof and shall be effective as of July 15, 2019 (the “Effecti
July 31, 2019	10-Q	Quarterly Report - 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00
July 30, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2019 (July 30, 2019) Acadia Healthcare Company, Inc.
July 30, 2019	EX-99	Acadia Healthcare Reports Second Quarter 2019 Revenue of $789.4 Million, EPS of $0.55 and Adjusted EPS of $0.61 Exhibit 99 Acadia Healthcare Reports Second Quarter 2019 Revenue of $789.4 Million, EPS of $0.55 and Adjusted EPS of $0.61 U.S. Same Facility Revenue Grows 6.6% Company Narrows 2019 Guidance FRANKLIN, Tenn.-(BUSINESS WIRE)-July 30, 2019-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2019. The Company reported revenue of $789.4
June 27, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 a52005688.htm ACADIA HEALTHCARE COMPANY, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 27, 2019 (June 26, 2019) Acadia Healthcare Company, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001
May 30, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events 8-K 1 a51991918.htm ACADIA HEALTHCARE COMPANY 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 30, 2019 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (St
May 30, 2019	EX-99.1	Update on Strategic priorities and initiatives Conference Call May 30, 2019 Safe harbor Some of the statements made in this presentation constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Exhibit 99.1 Update on Strategic priorities and initiatives Conference Call May 30, 2019 Safe harbor Some of the statements made in this presentation constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include any statements that address future results or occurrences. In some cases you can identify forward-loo
May 6, 2019	8-K	Submission of Matters to a Vote of Security Holders 8-K 1 d736544d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2019 Acadia Healthcare Company, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35331 45-2492228 (State or Other Jurisdiction of
May 1, 2019	10-Q	Quarterly Report - 10-Q Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0
April 30, 2019	EX-99	Acadia Healthcare Reports First Quarter 2019 Revenue of $760.6 Million, EPS of $0.34 and Adjusted EPS of $0.39 U.S. Same Facility Revenue Grows 6.1% EX-99 2 a51977086ex99.htm EXHIBIT 99 Exhibit 99 Acadia Healthcare Reports First Quarter 2019 Revenue of $760.6 Million, EPS of $0.34 and Adjusted EPS of $0.39 U.S. Same Facility Revenue Grows 6.1% FRANKLIN, Tenn.-(BUSINESS WIRE)-April 30, 2019-Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2019. The Company reported revenue of
April 30, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2019 Acadia Healthcare Company, Inc.
March 25, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 d724124d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 25, 2019 (March 19, 2019) Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35331 45-2492228 (State or
March 21, 2019	DEFA14A	ACHC / Acadia Healthcare Company, Inc. DEFA14A DEFA14A 1 d684789ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidentia
March 21, 2019	DEF 14A	ACHC / Acadia Healthcare Company, Inc. DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 1, 2019	EX-10.16	. (2) Exhibit 10.16 ELEVENTH AMENDMENT THIS ELEVENTH AMENDMENT (this “Amendment”) dated as of February 6, 2019 to the Credit Agreement referenced below is by and among ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation (the “Borrower”), the Guarantors identified on the signature pages hereto, the Lenders identified on the signature pages hereto and BANK OF AMERICA, N.A., in its capacity as Administ
March 1, 2019	EX-10.17	. (2) Exhibit 10.17 TWELFTH AMENDMENT THIS TWELFTH AMENDMENT (this “Amendment”) dated as of February 27, 2019 to the Credit Agreement referenced below is by and among ACADIA HEALTHCARE COMPANY, INC., a Delaware corporation (the “Borrower”), the Guarantors identified on the signature pages hereto, the Lenders identified on the signature pages hereto and BANK OF AMERICA, N.A., in its capacity as Administr
March 1, 2019	EX-21	Subsidiaries of the Company EX-21 4 achc-ex21268.htm EX-21 Exhibit 21 LIST OF SUBSIDIARIES Name of Subsidiary Jurisdiction of Incorporation or Organization (including dba name, if applicable) Abilene Holding Company, LLC Delaware Abilene Legacy Sub, LLC dba Abilene Behavioral Health Delaware Acadia Assurance Company Tennessee Acadia Chattanooga Holdings, LLC Tennessee Acadia Columbus JV Holdings, LLC Delaware Acadia Crestwyn
March 1, 2019	10-K	Annual Report - 10-K 10-K 1 achc-10k20181231.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from
February 28, 2019	EX-99	Acadia Healthcare Reports Fourth Quarter 2018 Results Provides Full Year and First Quarter 2019 Financial Guidance Exhibit 99 Acadia Healthcare Reports Fourth Quarter 2018 Results Provides Full Year and First Quarter 2019 Financial Guidance FRANKLIN, Tenn.
February 28, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 28, 2019 Acadia Healthcare Company, Inc.
February 12, 2019	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Acadia Healthcare Company, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00404A109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the approp
February 11, 2019	SC 13G/A	ACHC / Acadia Healthcare Company, Inc. / VANGUARD GROUP INC Passive Investment acadiahealthcarecoinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: Acadia Healthcare Co Inc Title of Class of Securities: Common Stock CUSIP Number: 00404A109 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appro

DE:7RA	20,20 €
MX:ACHC
IT:1ACHC	19,70 €

ACHC / Acadia Healthcare Company, Inc. - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)

Other Listings